Table 2.
Model | Diabetes OR (95%CI) (N = 778) | Pseudo R2 | ||
---|---|---|---|---|
| ||||
Predictors | OR (95% CI) | P-value | ||
1 | Q1 Amylase (<48 μ/L) | 1.97[1.01–3.83] | 0.04 | 0.052 |
Q2 Amylase (48–61 μ/L) | 1.59[0.83–3.05] | 0.16 | ||
Q3 Amylase (62–79 μ/L) | 0.85[0.40–1.82] | 0.68 | ||
Q4 Amylase (≥80 μ/L) | 1 | |||
2 | Q1 Amylase (<48 μ/L) | 1.65[0.83–3.27] | 0.15 | 0.066 |
Q2 Amylase (48–61 μ/L) | 1.43[0.73–2.75] | 0.30 | ||
Q3 Amylase (62–79 μ/L) | 0.83[0.39–1.76] | 0.62 | ||
Q4 Amylase (≥80 μ/L) | 1 | |||
BMI | 1.07[1.00–1.11] | 0.005 | ||
3 | Q1 Amylase (<48 μ/L) | 1.48[0.73–2.98] | 0.27 | 0.112 |
Q2 Amylase (48–61 μ/L) | 1.28[0.65–2.51] | 0.48 | ||
Q3 Amylase (62–79 μ/L) | 0.87[0.40–1.89] | 0.73 | ||
Q4 Amylase (≥80 μ/L) | 1 | |||
VAT | 1.12[1.07–1.17] | <0.001 | ||
4 | Q1 Amylase (<48 μ/L) | 1.52[0.75–3.08] | 0.24 | 0.113 |
Q2 Amylase (48–61 μ/L) | 1.29[0.65–2.55] | 0.46 | ||
Q3 Amylase (62–79 μ/L) | 0.89[0.41–1.92] | 0.76 | ||
Q4 Amylase (≥80 μ/L) | 1 | |||
BMI | 0.98[0.92–1.04] | 0.49 | ||
VAT | 1.13[1.08–1.19] | <0.001 | ||
5 | Q1 Amylase (<48 μ/L) | 1.51[0.75–3.07] | 0.25 | 0.117 |
Q2 Amylase (48–61 μ/L) | 1.30[0.66–2.57] | 0.45 | ||
Q3 Amylase (62–79 μ/L) | 0.87[0.40–1.89 | 0.73 | ||
Q4 Amylase (≥80 μ/L) | 1 | |||
BMI | 1.04[0.94–1.16] | 0.45 | ||
VAT | 1.13[1.07–1.18] | <0.001 | ||
SAT | 0.97[0.94–1.01] | 0.16 |
Diabetes: uncontrolled fasting plasma glucose ≥ 126 mg/dL. VAT: visceral adipose tissue area. All models were adjusted for age, ethnicity, and sex.